UB Paderborn / Katalog / Suche / in CDI

First-in-human phase I study of the OX40 agonist GSK3174998 with or without pembrolizumab in patients with selected advanced solid tumors (ENGAGE-1)

Journal for immunotherapy of cancer, 2023-03, Vol.11 (3), p.e005301

2023

Volltextzugriff (PDF)

Belantamab mafodotin in combination with novel agents in relapsed/refractory multiple myeloma: DREAMM-5 study design

Future oncology (London, England), 2021-06, Vol.17 (16), p.1987-2003

2021

Volltextzugriff (PDF)

ETS-TMPRSS2 fusion gene products in prostate cancer

Cancer biology & therapy, 2006-03, Vol.5 (3), p.254-255

2006

Volltextzugriff (PDF)

Inhibitory Effect of Ketoconazole on the Pharmacokinetics of a Multireceptor Tyrosine Kinase Inhibitor BMS-690514 in Healthy Participants: Assessing the Mechanism of the Interaction With Physiologically-Based Pharmacokinetic Simulations

Journal of clinical pharmacology, 2013-02, Vol.53 (2), p.217-227

2013

Volltextzugriff (PDF)

A phase I study of oral ixabepilone in patients with advanced solid tumors

Cancer chemotherapy and pharmacology, 2014-05, Vol.73 (5), p.1071-1078

2014

Volltextzugriff (PDF)

Food Increased the Bioavailability of BMS-690514, an Orally Active EGFR/HER2/VEGF Receptor Kinase Inhibitor, in Healthy Subjects

Journal of clinical pharmacology, 2012-09, Vol.52 (9), p.1350-1356

2012

Volltextzugriff (PDF)

Association of the ABCG2 C421A polymorphism with prostate cancer risk and survival

BJU international, 2008-12, Vol.102 (11), p.1694-1699

2008

Volltextzugriff (PDF)

Dreamm-5 Platform Trial: Belantamab Mafodotin (Belamaf) in Combination with Four Different Novel Agents in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)

BLOOD, 2020-11, Vol.136 (Supplement 1), p.1-2

2020

Volltextzugriff (PDF)

A Pilot Trial of a Carcinoembryonic Antigen/TRICOM—Based Vaccine and Radiation to Liver Metastases in Patients with Carcinoembryonic Antigen—Positive Solid Tumors

Clinical colorectal cancer, 2006-05, Vol.6 (1), p.72-75

2006

Volltextzugriff (PDF)

P-212: DREAMM-5 platform trial: Belantamab mafodotin (belamaf; GSK2857916) in combination with five different novel agents in patients with relapsed/refractory multiple myeloma (RRMM)

Clinical lymphoma, myeloma and leukemia, 2021-10, Vol.21, p.S156-S156

2021

Volltextzugriff (PDF)

Abstract CT027: A phase I, open-label study of GSK3174998 administered alone and in combination with pembrolizumab in patients (pts) with selected advanced solid tumors (ENGAGE-1)

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.CT027-CT027

2016

Volltextzugriff (PDF)

ENGAGE-1: A first in human study of the OX40 agonist GSK3174998 alone and in combination with pembrolizumab in patients with advanced solid tumors

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.TPS3107-TPS3107

2016

Volltextzugriff (PDF)

Abstract CT155: Clinical biomarker studies with an enhanced potency oncolytic HSV expressing an anti-CTLA-4 antibody, as a single agent and combined with nivolumab in patients with advanced solid tumors indicates potent immune activation

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.CT155-CT155

2022

Volltextzugriff (PDF)

Abstract 3752: Folate receptor expression prevalence across multiple tumor types and concordance between matched primary and metastatic tumor pairs

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.3752-3752

2010

Volltextzugriff (PDF)

Infectious Complications of High-Dose Cyclophosphamide Treatment in Autoimmune Disease

Blood, 2004-11, Vol.104 (11), p.5091-5091

2004

Volltextzugriff (PDF)

A Tat-induced auto-up-regulatory loop for superactivation of the human immunodeficiency virus type 1 promoter

Journal of Virology, 1995-12, Vol.69 (12), p.7437-7444

1995

Volltextzugriff (PDF)

Cooperative Inhibition of NF-κB and Tat-Induced Superactivation of Human Immunodeficiency Virus Type 1 Long Terminal Repeat

Proceedings of the National Academy of Sciences - PNAS, 1993-12, Vol.90 (23), p.11044-11048

1993

Volltextzugriff (PDF)

Pentoxifylline and other protein kinase C inhibitors down-regulate HIV-LTR NF-kappa B induced gene expression

Molecular medicine (Cambridge, Mass.), 1994-11, Vol.1 (1), p.31-43

1994

Volltextzugriff (PDF)

Tenidap inhibits replication of the human immunodeficiency virus-1 in cultured cells

Journal of acquired immune deficiency syndromes and human retrovirology, 1997-01, Vol.14 (1), p.13

1997

Volltextzugriff (PDF)

Inhibitors of HIV-1 transcription

Trends in Microbiology, 1994-05, Vol.2 (5), p.164-169

1994

Volltextzugriff (PDF)

Cooperative inhibition of NF-(kappa)B and Tat-induced superactivation of human immunodeficiency virus type 1 long terminal repeat

Proceedings of the National Academy of Sciences - PNAS, 1993-12, Vol.90 (23), p.11044

1993

Volltextzugriff (PDF)

Occlusal dysesthesia—A clinical guideline

Journal of oral rehabilitation, 2020-05, Vol.47 (5), p.651-658

2020

Volltextzugriff (PDF)

Minimum Resistance Anisotropy of Epitaxial Graphene on SiC

ACS applied materials & interfaces, 2018-02, Vol.10 (6), p.6039-6045

2018

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

First-in-human phase I study of the OX40 agonist GSK3174998 with or without pembrolizumab in patients with selected advanced solid tumors (ENGAGE-1)

Overall Survival and Long-Term Safety of Nivolumab (Anti-Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer

Belantamab mafodotin in combination with novel agents in relapsed/refractory multiple myeloma: DREAMM-5 study design

ETS-TMPRSS2 fusion gene products in prostate cancer

Inhibitory Effect of Ketoconazole on the Pharmacokinetics of a Multireceptor Tyrosine Kinase Inhibitor BMS-690514 in Healthy Participants: Assessing the Mechanism of the Interaction With Physiologically-Based Pharmacokinetic Simulations

A phase I study of oral ixabepilone in patients with advanced solid tumors

Food Increased the Bioavailability of BMS-690514, an Orally Active EGFR/HER2/VEGF Receptor Kinase Inhibitor, in Healthy Subjects

Association of the ABCG2 C421A polymorphism with prostate cancer risk and survival

Dreamm-5 Platform Trial: Belantamab Mafodotin (Belamaf) in Combination with Four Different Novel Agents in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)

Abstract CT150: A first-in-human phase I study of the OX40 agonist GSK3174998 (GSK998) +/- pembrolizumab in patients (Pts) with selected advanced solid tumors (ENGAGE-1)

A Pilot Trial of a Carcinoembryonic Antigen/TRICOM—Based Vaccine and Radiation to Liver Metastases in Patients with Carcinoembryonic Antigen—Positive Solid Tumors

P-212: DREAMM-5 platform trial: Belantamab mafodotin (belamaf; GSK2857916) in combination with five different novel agents in patients with relapsed/refractory multiple myeloma (RRMM)

Abstract CT027: A phase I, open-label study of GSK3174998 administered alone and in combination with pembrolizumab in patients (pts) with selected advanced solid tumors (ENGAGE-1)

ENGAGE-1: A first in human study of the OX40 agonist GSK3174998 alone and in combination with pembrolizumab in patients with advanced solid tumors

Abstract CT155: Clinical biomarker studies with an enhanced potency oncolytic HSV expressing an anti-CTLA-4 antibody, as a single agent and combined with nivolumab in patients with advanced solid tumors indicates potent immune activation

Abstract 3752: Folate receptor expression prevalence across multiple tumor types and concordance between matched primary and metastatic tumor pairs

Infectious Complications of High-Dose Cyclophosphamide Treatment in Autoimmune Disease

A Tat-induced auto-up-regulatory loop for superactivation of the human immunodeficiency virus type 1 promoter

Cooperative Inhibition of NF-κB and Tat-Induced Superactivation of Human Immunodeficiency Virus Type 1 Long Terminal Repeat

Pentoxifylline and other protein kinase C inhibitors down-regulate HIV-LTR NF-kappa B induced gene expression

Tenidap inhibits replication of the human immunodeficiency virus-1 in cultured cells

Inhibitors of HIV-1 transcription

Cooperative inhibition of NF-(kappa)B and Tat-induced superactivation of human immunodeficiency virus type 1 long terminal repeat

Occlusal dysesthesia—A clinical guideline

Minimum Resistance Anisotropy of Epitaxial Graphene on SiC

Suchergebnisse filtern